Nashville, TN4 Active Studies

Duchenne Muscular Dystrophy Clinical Trials in Nashville, TN

Find 4 actively recruiting duchenne muscular dystrophy clinical trials in Nashville, TN. Connect with local research sites and explore new treatment options.

4
Active Trials
2
Sponsors
1,100
Enrolling

Recruiting Duchenne Muscular Dystrophy Studies in Nashville

About Duchenne Muscular Dystrophy Clinical Trials in Nashville

Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.

There are currently 4 duchenne muscular dystrophy clinical trials recruiting participants in Nashville, TN. These studies are seeking a combined 1,100 participants. Research is being sponsored by Vanderbilt University Medical Center, Larry W. Markham. Clinical trial participation is free and participants receive study-related medical care at no cost.

Duchenne Muscular Dystrophy Clinical Trials in Nashville — FAQ

Are there duchenne muscular dystrophy clinical trials in Nashville?

Yes, there are 4 duchenne muscular dystrophy clinical trials currently recruiting in Nashville, TN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Nashville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you about next steps.

Are clinical trials in Nashville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nashville studies also compensate for your time and travel.

What duchenne muscular dystrophy treatments are being tested?

The 4 active trials in Nashville are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.

Data updated July 13, 2026 from ClinicalTrials.gov